JD Supra

MEDCAC Coverage with Evidence Development meeting offers CMS guidance on CED study requirements

On February 13-14, 2023, the Centers for Medicare & Medicaid Services (CMS) convened a virtual panel of the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) to evaluate changes to ...
Seeking Alpha

CMS Energy to exit non-utility renewables development

CMS Energy (CMS) up 1.7% in Tuesday's trading after beating Q2 adjusted earnings estimates by a penny and saying it plans to exit non-utility renewables ‌development following changes at NorthStar ...
JD Supra

CMS Proposes Guidance on Use of Real World Data for Coverage with Evidence Development

Real world data (RWD), which is data from actual patient treatments, provides valuable information on safety and effectiveness of innovative new health technologies, often at significantly lower cost ...
Health Affairs

Medicare “Coverage With Evidence Development” Leaps Into The Spotlight With CMS Draft National Coverage Decision On Alzheimer’s Drugs

The Centers for Medicare & Medicaid Services (CMS) issued a ground-breaking draft national coverage decision (NCD) on January 11, 2022, for Food & Drug Administration (FDA) approved monoclonal ...